As of 05 Nov 2026 02:06 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2025/022 (11 Apr 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Galantamine 8mg modified release capsulesaffected product · inferred from phrasing | Limited supply, as stated | late July 2025precision: late in the month · window end 31 Jul 2025, derived from “late July 2025” | notice of 11 Apr 2025 |
| Galantamine 16mg modified release capsulesaffected product · inferred from phrasing | Out of stock, as stated | late May 2025precision: late in the month · window end 31 May 2025, derived from “late May 2025” | notice of 11 Apr 2025 |
| Galantamine 24mg modified release capsulesaffected product · inferred from phrasing | Out of stock, as stated | late July 2025precision: late in the month · window end 31 Jul 2025, derived from “late July 2025” | notice of 11 Apr 2025 |
| Galantamine 8mg, 16mg and 24mg tabletsaffected product · inferred from phrasing | Discontinued, as stated | — not stated for this line | notice of 11 Apr 2025 |
| Galantamine 20mg/5ml oral solution sugar freenamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 11 Apr 2025 |
| Alternative solid dosage forms of acetylcholinesterase (AChE) inhibitors (donepezil tablets and rivastigmine capsules)class-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 11 Apr 2025 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Galantamine 20mg/5ml oral solution sugar free — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Galantamine
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 11 Apr 2025. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 11 Apr 2025 | Medicine Supply Notification: Galantamine 8mg, 16mg and 24mg modified-release capsules | Supply notification | Tier 2 | MSN/2025/022 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)17 Galantamine 8mg, 16mg and 24mg modified-release capsules · issued 22 Apr 2025 · valid until July 2025, as stated · matched by name PDF ↗